Detalhe da pesquisa
1.
New trends in prostate cancer diagnostics.
Rozhl Chir
; 101(3): 101-107, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35387465
2.
Management of BCG failure in non-muscle-invasive bladder cancer the present and the future.
Rozhl Chir
; 101(3): 108-113, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35387466
3.
Penile amputation for sarcoma.
Rozhl Chir
; 101(3): 134-137, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35387470
4.
Histologic tumor necrosis rate as a predictor of recurrence after surgical treatment for localized clear cell renal cell carcinoma.
Rozhl Chir
; 101(3): 114-118, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35387467
5.
Prognostic factors of renal cell carcinoma.
Rozhl Chir
; 101(10): 469-477, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36402558
6.
Risk of biochemical recurrence in patients with a positive surgical margin after radical prostatectomy.
Rozhl Chir
; 101(3): 129-133, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35387469
7.
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.
Ann Oncol
; 30(11): 1697-1727, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31740927
8.
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
World J Urol
; 36(11): 1775-1781, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30171454
9.
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.
World J Urol
; 36(10): 1621-1627, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-29721611
10.
MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
Neoplasma
; 63(5): 799-808, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27468885
11.
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Ann Oncol
; 26(8): 1754-9, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25969370
12.
The prognostic value of T1 bladder cancer substaging: a single institution retrospective study.
Urol Int
; 92(2): 150-6, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24481124
13.
Cancer incidence and mortality in the Czech Republic.
Klin Onkol
; 27(6): 406-23, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25493580
14.
Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results.
Neoplasma
; 60(3): 295-301, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23452234
15.
Positron emission tomography and clinical predictors of survival in primary extragonadal germ cell tumors.
Klin Onkol
; 25(3): 178-83, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22724566
16.
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.
Actas Urol Esp (Engl Ed)
; 45(6): 473-478, 2021.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-34147426
17.
[Not Available]. / Résultats oncologiques du traitement des TVES≤pT2 de l'uretère pelvien par néphro-urétérectomie, résection segmentaire et chirurgie endoscopique : résultats d'une étude multicentrique européenne.
Prog Urol
; 25(13): 807, 2015 Nov.
Artigo
Francês
| MEDLINE | ID: mdl-26544377
18.
Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
Urol Int
; 80(4): 413-8, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18587253
19.
[Difficulties in routine diagnostics of urothelium lesions]. / Problémy v rutinní diagnostice uroteliálních lézí.
Cesk Patol
; 44(2): 29-34, 2008 Apr.
Artigo
Tcheco
| MEDLINE | ID: mdl-18819323
20.
[Primary synovial sarcoma of the kidney]. / Primární synoviální sarkom ledviny--popis dvou prípadu.
Cesk Patol
; 44(1): 20-2, 2008 Jan.
Artigo
Tcheco
| MEDLINE | ID: mdl-18333330